EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma

Mohammed S I Mansour iD, Adela Huseinzade, Tomas Seidal, Kim Hejny, Athar Maty, Fereshteh Taheri-Eilagh, Ulrich Mager, Annika Dejmek, Katalin Dobra, Hans Brunnström iD

Cytopathology · 2023

DOI: 10.1111/cyt.13265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytopathology, 2023. Verfasst von Mohammed S I Mansour und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cytology, Halland Hospital Halmstad, Sweden. Hauptthemen laut MEDLINE: Lung Neoplasms, Mesothelioma, Malignant, Mesothelioma, Pleural Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Franke and Margareta Bergqvist Foundation, Regional Research and Development Funding (FoU) (grants HALLAND-966006, HALLAND-972700, HALLAND-978699, SKÅNE-2021/0752 and SKÅNE-2022/1248), Sparbank Foundation in Varberg (grants RFSP15 and RFSP37).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Traditionally, the diagnosis of pleural mesothelioma is based on histological material. Minimally invasive effusion cytology specimens are an alternative that, like biopsies, require ancillary analyses. Validation of immunohistochemical (IHC) analyses on cytology, including the surrogate markers for molecular alterations BAP1 and MTAP, is of interest.

Methods

IHC for eight different markers was performed on 59 paired formalin‐fixed, paraffin‐embedded pleural biopsies and pleural effusion cell blocks with mesothelioma. Immunoreactivity in ≥10% of tumour cells was considered positive/preserved. The concordance between histological and cytological materials was assessed.

Results

The overall percentage of agreement between the histological epithelioid component in 58 biopsies and paired cell blocks was 93% for calretinin, 98% for CK5, 97% for podoplanin, 90% for WT1, 86% for EMA, 100% for desmin, 91% for BAP1, and 72% for MTAP. For 11 cases with biphasic or sarcomatoid histology, the concordance between cytology and the histological sarcomatoid component was low for calretinin, CK5, and WT1 (all ≤45%). For the whole cohort, loss of both BAP1 and MTAP was seen in 40% while both markers were preserved in 11% of the biopsies for epithelioid histology. The corresponding numbers were 54% and 8%, respectively, for the paired cell blocks.

Conclusions

Generally, a high concordance for IHC staining was seen between paired biopsies and pleural effusion cell blocks from mesotheliomas, but the somewhat lower agreement for WT1, EMA, and especially MTAP calls for further investigation and local quality assurance. The lower concordance for the sarcomatoid subtype for some markers may indicate biological differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMesothelioma, MalignantMesotheliomaPleural NeoplasmsPleural EffusionSarcomaHumansCalbindin 2Tumor Suppressor ProteinsBiomarkers, TumorImmunohistochemistryBiopsyDiagnosis, Differential

Stichwörter der Autor:innen

BAP1CK5EMAMTAPcalretininpodoplanin

Substanzen

Calbindin 2Tumor Suppressor ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Cytology, Halland Hospital Halmstad, Sweden.
  • Department of Clinical Sciences Lund, Division of Pathology, Lund University, Lund, Sweden.
  • Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
  • Division of Medical Cancer Diagnostics Huddinge (MCDH), Pathology Core Facility Karolinska (PCFK), Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Division of Respiratory and Internal Medicine, Department of Clinical Medicine, Halland Hospital Halmstad, Halmstad, Sweden.
  • Department of Translational Medicine in Malmö, Lund University, Malmö, Sweden.

ORCID-Profile: Mohammed S I Mansour, Hans Brunnström

Förderung

  • Franke and Margareta Bergqvist Foundation
  • Regional Research and Development Funding (FoU) (grants HALLAND-966006, HALLAND-972700, HALLAND-978699, SKÅNE-2021/0752 and SKÅNE-2022/1248)
  • Sparbank Foundation in Varberg (grants RFSP15 and RFSP37)
  • Swedish Cancer Society (grants CAN-2017/997 and CAN-2020/0786)
  • Swedish Governmental Funding of Clinical Research (ALF), 13733
  • Cancerfonden

Zitieren

APA

Mansour, M. S. I., Huseinzade, A., Seidal, T., Hejny, K., Maty, A., Taheri-Eilagh, F., Mager, U., Dejmek, A., Dobra, K., & Brunnström, H. (2023). Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma. Cytopathology. https://doi.org/10.1111/cyt.13265

Vancouver

Mansour MSI, Huseinzade A, Seidal T, Hejny K, Maty A, Taheri-Eilagh F, et al. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma. Cytopathology. 2023. doi:10.1111/cyt.13265

BibTeX
@article{Mansour2023,
  author = {Mansour, Mohammed S I and Huseinzade, Adela and Seidal, Tomas and Hejny, Kim and Maty, Athar and Taheri-Eilagh, Fereshteh and Mager, Ulrich and Dejmek, Annika and Dobra, Katalin and Brunnström, Hans},
  title = {Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma},
  journal = {Cytopathology},
  year = {2023},
  doi = {10.1111/cyt.13265}
}
Kostenlos starten →